Medical Management of Nasal Polyps
Introduction to Treatment
- The American Academy of Allergy, Asthma, and Immunology recommends intranasal corticosteroids as the first-line treatment for nasal polyps, with oral corticosteroids reserved for severe cases, and leukotriene modifiers as potential adjunctive therapy 1, 2
First-Line Treatment: Intranasal Corticosteroids
- Intranasal corticosteroids are effective in improving sense of smell and reducing nasal congestion in patients with nasal polyps 1
- Twice-daily dosing is more effective than once-daily dosing for optimal control of nasal polyps 1
Second-Line Treatment: Oral Corticosteroids
- For severe nasal polyposis, a short course of oral prednisone is effective in reducing symptoms, polyp size, and improving nasal flow 1
- After the initial reduction with oral steroids, maintenance therapy should be continued with intranasal corticosteroids 1
Adjunctive Therapies
- Leukotriene modifiers have shown subjective improvement in nasal polyp symptoms when used as add-on therapy to intranasal corticosteroids 1
- After endoscopic sinus surgery, montelukast has shown similar efficacy to postoperative nasal beclomethasone in controlling recurrence rates 1
- For patients with Aspirin-Exacerbated Respiratory Disease and nasal polyps, aspirin desensitization followed by long-term daily aspirin therapy may reduce nasal symptoms, frequency of sinus infections, requirement for nasal polypectomies, and need for systemic corticosteroids 3, 4
Special Considerations
- Nasal polyps are more difficult to control in patients with asthma and Aspirin-Exacerbated Respiratory Disease 1
- Patients with Aspirin-Exacerbated Respiratory Disease and nasal polyps have worse outcomes with functional endoscopic sinus surgery than aspirin-tolerant patients 3
- Chronic nasal polyposis is associated with reduced quality of life and greater risk of sleep disturbances 1, 5
- Nasal polyps have a prevalence of 2-4% in the general population and usually occur after age 40 years 1, 6
Management of Nasal Polyps with Biologics and Adjunctive Therapies
Treatment Options
- Different delivery methods for intranasal corticosteroids, including nasal spray, rinse/irrigation, exhalation delivery system, drops, and stents/dressing, are available with varying levels of medication penetration into the sinuses, as noted by the American Academy of Allergy, Asthma, and Immunology 7
- Biologics are emerging as an important treatment option for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), particularly for patients with severe disease, according to the American College of Allergy, Asthma, and Immunology 7
- Saline irrigation may help improve mucociliary clearance and secondarily improve the patency of the sinus ostia, as suggested by the American Academy of Otolaryngology 8
Initial Assessment and Treatment Algorithm
- Initial assessment should include evaluation of polyp size and associated conditions, such as asthma and Aspirin-Exacerbated Respiratory Disease (AERD), as recommended by the American Academy of Allergy, Asthma, and Immunology 7
- Checking for complications requiring urgent referral, such as orbital swelling, diplopia, and forehead swelling, is crucial, as noted by the American College of Surgeons 9
Treatment of Nasal Polyps with Corticosteroids
Introduction to Corticosteroid Treatment
- The European Position Paper on Rhinosinusitis recommends 1-2 courses of systemic corticosteroids per year as a useful addition to nasal corticosteroid treatment in patients with partially or uncontrolled disease 10
Oral Corticosteroids
- Short courses of oral prednisone (25-60 mg daily for 5-20 days) are reserved for severe nasal polyposis and provide rapid reduction in symptoms, polyp size, and improved nasal airflow 10
- Oral methylprednisolone (32 mg/day tapering over 20 days) reduces symptoms for 4 weeks and polyp scores for 55 days 10
Adjunctive Therapies
- Montelukast 10 mg daily has shown subjective improvement in nasal polyp symptoms when used as add-on therapy to intranasal corticosteroids, though evidence is mixed 11
- One study showed significant benefit for total symptoms, headache, sense of smell, and sneezing at 8-12 weeks when combined with oral and intranasal corticosteroids 12
Important Caveats
- The EPOS2020 steering group suggests in general not to use nasal decongestants in chronic rhinosinusitis with nasal polyps 13
- Nasal decongestants (oxymetazoline, xylometazoline) are NOT recommended for chronic use in nasal polyps despite one small study showing benefit, due to concerns about rebound congestion 13